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The APO*E3-Leiden mouse as an animal model
for basal laminar deposit
Mike KliVen, Esther Lutgens, Mat J A P Daemen, Ebo D de Muinck, Cornelia M Mooy,
Paulus T V M de Jong
Abstract
Aim—To investigate the APO*E3-Leiden
mouse as an animal model for age related
maculopathy (ARM) related extracellular
deposits.
Methods—Eyes were obtained from
APO*E3-Leiden transgenic mice on a
high fat/cholesterol (HFC) diet (n=12) or
on a normal mouse chow (n=6), for 9
months. As controls, eyes were collected
from APO-E knockout mice on the same
diets. From each mouse one eye was proc-
essed for microscopic evaluation and
immunohistochemistry with a polyclonal
antibody directed against human apo-E.
Electron microscopy was also performed.
Results—All 12 eyes of the APO*E3-
Leiden mice on an HFC diet contained
basal laminar deposit (BLD; class 1 to
class 3), whereas two of six APO*E3-
Leiden mice on normal chow showed BLD
class 1. The ultrastructural aspects of this
BLD were comparable with those seen in
early BLD in humans, and BLD showed
immunoreaction with anti-human-apo-E
antibodies. No BLD was found in any of
the control mice. Drusen were not de-
tected in any of the mice.
Conclusion—These results indicate that
APO*E3-Leiden mice can be used as ani-
mal model for the pathogenesis of BLD,
and that a HFC diet enhances the accu-
mulation of this deposit. Furthermore,
this study supports the previously sug-
gested involvement of dysfunctional apo-E
in the accumulation of extracellular de-
posits in ARM.
(Br J Ophthalmol 2000;84:1415–1419)
The late stages of age related maculopathy
(ARM) are called age related macular degen-
eration (AMD), and are subdivided into dry
AMD (geographic atrophy) and wet AMD
(neovascular AMD).1 These late stages are the
main cause of blindness in the elderly popula-
tion in the Western world.2 3 Many histopatho-
logical changes can be seen in ARM.4 5 Among
these changes are drusen and basal laminar
deposit (BLD), which are both assumed to be
important determinants of AMD.6–11 Basal
laminar deposit and drusen are both extracel-
lular deposits. Basal laminar deposit is located
between the cell membrane of the retinal
pigment epithelium (RPE) and its basement
membrane.4 5 Drusen are located between the
basement membrane of the RPE and the
remainder of Bruch’s membrane, or external to
a diVuse thickening of the inner aspect of
Bruch’s membrane.4 5 Unfortunately, the
chemical composition and origin of BLD and
drusen have been only partly clarified, mainly
by immunohistochemical techniques.12–15
Recently, we have demonstrated the pres-
ence of apolipoprotein-E (apo-E) in drusen
and BLD.16 Apo-E is a transport molecule for
very low density lipoproteins, high density
lipoproteins, and chylomicrons, and contains a
low density lipoprotein (LDL) receptor bind-
ing site to facilitate cellular recognition,
internalisation, and degradation of lipoprotein
particles.17 Furthermore, we have found a
decreased risk for AMD in people carrying an
apo-å4 allele compared with people homo-
zygous for apo-å3.16 These results suggest the
involvement of apo-E in AMD.
One of the major problems in studying ARM
and its associated deposits is the lack of fresh
macular material from human ARM eyes, and
the absence of an animal model. Therefore, we
investigated whether ARM associated age
related deposits were present in APO*E3-
Leiden transgenic mice. These mice carry a
dysfunctional form of human apo-E3, that was
discovered in a family from the Dutch town
Leiden. These patients have hyperlipoprotein-
aemia and develop early onset atherosclerosis.18
Materials and methods
MICE
All procedures complied with the Association
for Research in Vision and Ophthalmology
statement for the use of animals in ophthalmic
and vision research.
Transgenic mice expressing the human
APO*E3-Leiden gene (and producing a dys-
functional form of human apo-E3), and
APO-E knockout mice were generated as
described earlier.18 19 For the present study,
mice of the F10 generation were used. Before
entry into the study, animals were kept on a
standard mouse chow (SRM-A, Hope Farms,
Woerden, Netherlands). At the mean age of 37
(SD 0.6) weeks, 12 APO*E3-Leiden mice and
12 APO-E knockout mice were put on a high
fat/cholesterol (HFC) diet containing 15%
cacao butter, 0.5% cholate, 1% cholesterol,
40.5% sucrose, 10% corn starch, 1% corn oil,
and 4.7% cellulose (Hope Farms) for 9
months. Six APO*E3-Leiden mice and 12
APO-E knockout mice received standard
mouse chow for 9 months.
The mice in this study were primarily used
for research on atherosclerosis.20 All mice were
housed under standard conditions on the shelf
below the top one in a room with normal fluo-
rescent light exposure. After completion of the
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diet according to protocol, each mouse was
anaesthetised with xylazine (0.0025 ml/g) and
ketamine (0.001 ml/g) intraperitoneally, and
the arterial tree was perfused with 0.9% NaCl
(3 minutes) and 10% phosphate buVered
formalin (pH 7.4, 3 minutes), both containing
20% nitroglycerine. Subsequently, both eyes
were taken out and fixed overnight in 10%
phosphate buVered formalin. One of the eyes
(random) of each mouse was used for this
study and the central retina was embedded in
paraYn for histopathological classification and
immunohistochemistry.
HISTOPATHOLOGICAL CLASSIFICATION OF MOUSE
CENTRAL RETINA
ParaYn sections (5 µm) were stained with hae-
matoxylin and eosin, the periodic acid SchiV
reaction, and Mallory staining. The retinas
were histologically classified according to the
independent grading of both drusen and BLD.
This classification of drusen and BLD has been
described earlier in human eyes.5 21 In brief: no
BLD (class 0); small solitary patches of BLD
(class 1); a thin continuous layer of BLD (class
2); a thick layer of BLD of at least half the
height of the RPE cells (class 3). No drusen
(class 0); 1–3 drusen (class 1); 4–10 drusen
(class 2); many or confluent drusen (class 3).
IMMUNOHISTOCHEMISTRY
ParaYn sections (5 µm) of all retinas were
mounted on 3-amino-propyl-tri-oxy-silane
(Sigma, St Louis, MO, USA) coated glass
slides. After dewaxing and rehydration they
were rinsed with water and phosphate buVered
saline, and incubated with 5.5 mU/ml pronase
E (Sigma, St Louis, MO, USA) for 6 minutes
at 37°C. The slides were then placed in a
Sequenza Immunostaining Workstation (Life
Sciences International, Velthoven, Nether-
lands), and incubated for 30 minutes with a
rabbit polyclonal antibody directed against
human apo-E (kindly supplied by L Havekes
from the Gaubius Laboratory, Leiden, Nether-
lands). This antibody does not cross react with
mouse apo-E. After washing with phosphate
buVered saline, the slides were incubated for
30 minutes with biotinylated secondary anti-
bodies (Multilink, 1:75 dilution, Biogenex, San
Ramon, MO, USA). The slides were washed
again and incubated for 30 minutes with alka-
line phosphatase conjugated streptavidin (Bio-
genex, San Ramon, MO, USA, dilution 1:50).
Finally the slides were rinsed with 0.2 M
TRIS-HCl pH 8.0, and stained for 30 minutes
with 0.3% new fuchsin/TRIS-HCl pH 8.0 in
combination with Naphthol-AS-MX-sulphate
(Sigma, St Louis, MO, USA). The sections
were counterstained with Mayer’s haematoxy-
lin for 15 seconds, rinsed for 10 minutes with
water, and covered. In negative controls, the
primary antibody was replaced by normal rab-
bit serum (Dako, Glostrup, Denmark, dilution
1:10).
ELECTRON MICROSCOPY
Electron microscopy was performed on two
eyes from each study group (n=8) to compare
the ultrastructural aspects of this mouse BLD
with human BLD. The eyes were prepared for
electron microscopy as described earlier.22
They were embedded in epoxy resin, after
dehydration with a grading series of acetone.
Ultrathin sections (70–80 nm thickness) were
mounted on uncoated mesh 300 copper grids.
After staining for 30 minutes with uranyl
acetate and 2 minutes with lead citrate, the
sections were examined with a Zeiss EM 902
transmission electron microscope.
Results
HISTOPATHOLOGICAL CLASSIFICATION OF MOUSE
CENTRAL RETINA
All 12 eyes of the APO*E3-Leiden mice on a
HFC diet for 9 months contained BLD. Five
eyes had BLD class 1, six eyes had BLD class
2, and one eye had BLD class 3 (Fig 1A). Of
the six APO*E3-Leiden mice fed a normal
mouse chow, two eyes contained BLD class 1,
three eyes had no BLD (Fig 1B), and one eye
could not be investigated properly because of
overlapping tissue layers after processing.
None of the APO-E knockout mice (either
on HFC or normal diet) contained any BLD
(that is, class 0) or any type of drusen (Fig 1C
and D). There were no diVerences between the
retinas of APO*E3-Leiden mice and APO-E
knockout mice by light microscopy.
None of the eyes had any type of drusen.
IMMUNOHISTOCHEMICAL LOCALISATION OF
APOLIPOPROTEIN-E
Human apo-E was immunohistochemically
localised in BLD in all eyes of APO*E3-Leiden
mice containing BLD (Fig 1E). In APO*E3-
Leiden mice a diVuse staining was noted
throughout the BLD and over some plasma
remnants in blood vessels.
No positive staining with the apo-E antibody
in APO-E knockout mice was found.
ELECTRON MICROSCOPY
Ultrastructurally, the major part of BLD
(located between the RPE cell membrane and
its basement membrane) in these APO*E3-
Leiden mice appeared as homogeneous base-
ment membrane-like material (Fig 2), but also
minute amounts of fibrous long spacing
collagen were present (not shown).
Discussion
We have demonstrated the presence of BLD in
all eyes from APO*E3-Leiden mice on a HFC
diet for 9 months. Additionally, 33% of eyes
from APO*E3-Leiden mice on a normal
mouse chow also showed BLD. This mouse
BLD showed positive immunoreactivity for
human apo-E. Because the human apo-E anti-
body does not cross react with mouse apo-E,
and APO-E knockout mice did not show posi-
tive immunoreactivity at all, it is reasonable to
assume that the immunoreactivity of BLD in
APO*E3-Leiden mice was solely due to the
presence of human apo-E.
Various ratios between the individual com-
ponents of human BLD have been de-
scribed.4 22 23 The ultrastructural aspects of the
mouse BLD we have found in this study are
comparable with early BLD in humans.24
1416 KliVen, Lutgens, Daemen, et al
www.bjophthalmol.com
 on 28 November 2006 bjo.bmj.comDownloaded from 
Vesicular deposits such as those described in
diVuse thickening of Bruch’s membrane
(sometimes referred to as basal linear deposit)
were not seen in this BLD.4
It has been reported recently that wild type
C57BL/6 mice on an HFC diet do not develop
light microscopically detectable amounts of
extracellular deposits, although some diVuse
thickening of Bruch’s membrane was demon-
strated with electron microscopy.25 The eyes
used in this study were obtained from mice that
were used in an atherosclerosis related research
project. The perfusion fixation technique
(based on formaldehyde) that was used in this
study resulted in optimal eye tissue preserva-
tion for (immuno)histochemical purposes.
However, this technique is not optimal for
electron microscopy, and could have created
some artefacts. Therefore, we only used
electron microscopy for the location and
ultrastructure of relatively large amounts of
BLD, and not for possible minute changes not
detectable by light microscopy (for example, in
Bruch’s membrane). Further studies especially
designed for electron microscopy need to be
done in order to elucidate the changes in RPE
and Bruch’s membrane in these mice.
Recently, we have demonstrated apo-E in
BLD and drusen in human maculas, and we
have found a decreased risk for AMD in people
carrying an apo-å4 allele compared with
people homozygous for apo-å3.16 Most ani-
mals, including mice, carry only one allele of
apo-E that is E4-like.26 This allele is much
more eYcient in its function (for example, in
its receptor binding properties) than apo-E3.27
It is thought that this is one of the reasons that
normal mice are very resistant to the develop-
ment of atherosclerosis.28 It has been demon-
strated previously that APO*E3-Leiden and
APO-E knockout mice on an HFC diet
develop severe atherosclerosis,29 with many
features that are characteristic of human
atherosclerotic plaques.20 Therefore, we have
chosen the APO-E knockout mice as a control
group instead of normal (apo-E4 carrying)
mice, which would not have developed this
severe atherosclerosis. APO*E3-Leiden and
APO-E knockout mice on normal mouse chow
do not develop atherosclerosis. The fact that
more BLD was found in this model in athero-
sclerotic APO*E3-Leiden animals than in
non-atherosclerotic APO*E3-Leiden animals
supports the association between AMD and
atherosclerosis that has been found in human
epidemiologic studies.30 On the other hand
APO-E knockout mice on an HFC diet do
develop atherosclerosis but no BLD. There-
fore, it seems likely that BLD in these
APO*E3-Leiden mice is related to a dysfunc-
tional apo-e, and that this BLD is attenuated
by atherosclerosis/hyperlipidaemia.
Drusen and Bruch’s membrane contain
various amounts of phospholipids and neu-
trolipids. These lipids are assumed to cause a
diVusion barrier between the choriocapillaris
and the RPE, but the mechanism by which
these lipids accumulate is unknown.31–34 Most
research points to accumulation of inappropri-
ately metabolised products from the RPE, but
Figure 1 Light microscopic images of (A) a continuous layer (class 2) of basal laminar
deposit (arrow), between the retinal pigment epithelium (R) and Bruch’s membrane, in the
central retina of an APO*E3-Leiden mouse on a high fat/cholesterol (HFC) diet. (B) the
central retina from an APO*E3-Leiden mouse on normal chow,without basal laminar deposit
(BLD class 0).Note the thin Bruch’s membrane between the RPE (R) and the choroidal
melanin (M). (C,D) The central retinas of APO-E knockout mice (without BLD) on a (C)
normal, and (D) HFC diet, respectively. (E,F) a continuous layer (class 2) of basal laminar
deposit, between the RPE and Bruch’s membrane, in the central retina of an APO*E3-Leiden
mouse on an HFC diet. (E) Stained with an anti-human apo-e antibody (BLD stains red).
(F) Negative control. Scale bar indicates 10 µm.
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also serum derived origin should be consid-
ered. Since APO*E3-Leiden has a lower aYn-
ity for the LDL receptor, and causes a higher
plasma level of apo-E,35 APO*E3-Leiden in
BLD could be derived from the chorio-
capillaris. On the other hand it could be
hypothesised that apo-E plays a part in the
transport of retinal lipids, which have a high
turnover, especially in the photoreceptors. A
dysfunctional APO*E3-Leiden could alter the
lipid transport system, and cause accumulation
of BLD. Degeneration of photoreceptors is a
main event in the end stages of ARM.
Therefore, the presence of apo-E in BLD
could be due to the known involvement of
apo-E in the repair of damaged neural tissue.36
Recently, Schneeberger et al demonstrated the
presence of apo-E in the subretinal space in
several forms of exudative retinal detachments,
which could support this hypothesis.37 Further-
more, apo-E also accumulates in extracellular
deposits in Alzheimer’s disease, another neuro-
degenerative disease.38 39 Another explanation
for the presence of apo-E in BLD could be the
fact that apo-E is easily bound to glycos-
aminoglycans, molecules that are known to be
present in BLD.12 13 40
One of the major problems in studying ARM
is the lack of fresh human tissue necessary for
most of the biochemical techniques. Further-
more, the macular area in the eye consists of
only a small amount of tissue. A piece of
macular tissue of one eye (about 0.1 cm3) con-
tains about 2 mg total protein. Highly special-
ised techniques—for example, two dimen-
sional polyacrylamide gel electrophoresis and
two dimensional electrophoresis on cellulose
acetate membranes, have to be used to cope
with these small amounts of human eye
tissue.11 13 Therefore, the APO*E3-Leiden
mouse model could prove to be helpful for fur-
ther investigation (on the origin) of BLD. It
also provides an opportunity to collect BLD
within a few minutes post mortem, which is
necessary for many biochemical techniques,
but almost impossible from a human source.
Additionally, this animal model could be used,
despite the lack of a real macula, in interven-
tion studies in order to prevent the accumula-
tion of BLD, which is histologically an impor-
tant feature associated with the development of
ARM.
In conclusion our results indicate that
APO*E3-Leiden mice can be used as an
animal model for the pathogenesis of BLD,
and that an HFC diet enhances the accumula-
tion of this deposit. Furthermore, this study
supports the previously suggested involvement
of dysfunctional apo-E in the accumulation of
extracellular deposits in ARM.
1 Bird AC, Bressler NM, Bressler SB, et al. An international
classification and grading system for age-related maculopa-
thy and age-related macular degeneration. Surv Ophthalmol
1995;39:367–74.
2 Klein R, Klein BEK, Linton KLP. Prevalence of age-related
maculopathy. The Beaver Dam eye study. Ophthalmology
1992;99:933–43.
3 Klaver CCW, Wolfs RCW, Vingerling JR, et al. Age-specific
prevalence and causes of blindness and visual impairment
in an older population. Arch Ophthalmol 1998;116:653–8.
4 Green WR, Enger C. Age-related macular degeneration his-
topathologic studies. The 1992 Lorenz E. Zimmerman
Lecture. Ophthalmology 1993;100:1519–35.
5 KliVen M, van der Schaft TL, Mooy CM, et al.Morphologic
changes in age-related maculopathy. Microsc Res Tech 1997;
36:106–22.
6 Bird AC. Bruch’s membrane change with age. Br J Ophthal-
mol 1992;76:166–8.
7 PauleikhoV D, Barondes MJ, Minassian D, et al. Drusen as
risk factors in age-related macular disease. Am J Ophthal-
mol 1990;109:38–43.
8 Green WR, McDonnell PJ, Yeo JH. Pathologic features of
senile macular degeneration. Ophthalmology 1985;92:615–
27.
9 Sarks SH. Ageing and degeneration in the macular region: a
clinico-pathological study. Br J Ophthalmol 1976;60:324–
41.
10 Sheraidah G, Steinmetz R, Maguire J, et al. Correlation
between lipids extracted from Bruch’s membrane and age.
Ophthalmology 1993;100:47–51.
11 KliVen M, de Jong PTVM, Luider TM. Protein analysis of
human maculae in relation to age-related maculopathy.Lab
Invest 1995;73:267–72.
12 KliVen M, Mooy CM, Luider TM, et al. Analysis of carbo-
hydrate structures in basal laminar deposit in aging human
maculae. Invest Ophthalmol Vis Sci 1994;35:2901–5.
13 KliVen M, Mooy CM, Luider TM, et al. Identification of
glycosaminoglycans in age-related macular deposits. Arch
Ophthalmol 1996;114:1009–14.
14 Mullins RF, Russell SR, Anderson DH, et al.Drusen associ-
ated with aging and age-related macular degeneration con-
tain proteins common to extracellular deposits associated
with atherosclerosis, elastosis, amyloidosis, and dense
deposit. FASEB J 2000;14:835–46.
15 Mullins R, Johnson LV, Anderson DH, et al. Characteriza-
tion of drusen-associated glycoconjugates. Ophthalmology
1997;104:288–94.
16 Klaver CC, KliVen M, van Duijn CM, et al.Genetic associ-
ation of apolipoprotein E with age-related macular degen-
eration. Am J Hum Genet 1998;63:200–206.
17 Mahley RW. Apolipoprotein E: cholesterol transport protein
with expanding role in cell biology. Science 1988;240:622–
30.
18 Van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, et
al.Transgenic mice carrying the apolipoprotein E3-Leiden
gene exhibit hyperlipoproteinemia. J Biol Chem 1993;268:
10540–5.
19 Van Ree JH, van den Broek WJ, van der Zee A, et al. Inacti-
vation of Apo-e and Apo-c1 by two consecutive rounds of
Figure 2 Electron micrograph of basal laminar deposit (BLD) class 2, between the cell
membrane of the retinal pigment epithelium (RPE) and the basement membrane of the
RPE, in a central retina from an APO*E3-Leiden mouse on a high fat/cholesterol diet.
Furthermore, there is an increase and elongation of the basal infoldings of the RPE (*).
Uranyl acetate/lead citrate staining. Scale bar indicates 1.1 µm.N = nucleus of RPE; C =
choriocapillaris.
1418 KliVen, Lutgens, Daemen, et al
www.bjophthalmol.com
 on 28 November 2006 bjo.bmj.comDownloaded from 
gene targeting: eVects on mRNA expression levels of gene
cluster members. Hum Mol Genet 1995;4:1403–9.
20 Lutgens E, Daemen MJAP, Kockx M, et al. Atherosclerosis
in APO*E3-Leiden transgenic mice: from proliferative to
atheromatous stage. Circulation 1999;99:276–83.
21 Van der Schaft TL, de Bruijn WC, Mooy CM, et al. Histo-
logic features of the early stages of age-related macular
degeneration. A statistical analysis. Ophthalmology 1992;99:
278–86.
22 Van der Schaft TL, de Bruijn WC, Mooy CM, et al. Is basal
laminar deposit unique for age-related macular degenera-
tion? Arch Ophthalmol 1991;109:420–5.
23 LöZer KU, Lee WR. Basal linear deposit in the human
macula. Graefes Arch Clin Exp Ophthalmol 1986;224:493–
501.
24 Van der Schaft TL, de Bruijn WC, Mooy CM, et al. Basal
laminar deposit in the aging peripheral human retina.
Graefes Arch Clin Exp Ophthalmol 1993;231:470–5.
25 Miceli MV, Newsome DA, Tate DJ, et al.Pathologic changes
in the retinal pigment epithelium and Bruch’s membrane of
fat-fed atherogenic mice. Curr Eye Res 2000;20:8–16.
26 Chan L, Li W-H. Apolipoprotein variation among diVerent
species. Curr Opin Lipidol 1991;2:96–103.
27 Wilson C, Wardell MR, Weisgraber KH, et al. Three-
dimensional structure of the LDL receptor-binding do-
main of human apolipoprotein E. Science 1991;252:1817–
22.
28 Breslow J. Mouse models of atherosclerosis. Science
1996;272:685–8.
29 Van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, et
al. Diet-induced hyperlipoproteinemia and atherosclerosis
in apolipoprotein E3-Leiden transgenic mice. J Clin Invest
1994;93:1403–10.
30 Vingerling JR, Dielemans I, Bots ML, et al. Age-related
macular degeneration is associated with atherosclerosis.
The Rotterdam study. Am J Epidemiol 1995;142:404–9.
31 PauleikhoV D, Zuels S, Sheraidah GS, et al. Correlation
between biochemical composition and fluorescein binding
of deposits in Bruch’s membrane. Ophthalmology 1992;99:
1548–53.
32 Holz FG, Sheraidah G, PauleikhoV D, et al.Analysis of lipid
deposits extracted from human macular and peripheral
Bruch’s membrane. Arch Ophthalmol 1994;112:402–6.
33 Starita C, Hussain AA, Marshall J. Decreasing hydraulic
conductivity of Bruch’s membrane: relevance to photore-
ceptor survival and lipofuscinoses. Am J Med Genet
1995;57:235–7.
34 Moore DJ, Hussain AA, Marshall J. Age-related variation in
the hydraulic conductivity of Bruch’s membrane. Invest
Ophthalmol Vis Sci 1995;36:1290–7.
35 Havekes L, de Wit E, Gevers Leuven J, et al. Apolipoprotein
E*3-Leiden. A new variant of human apolipoprotein E
associated with familial type III hyperlipoproteinemia.
Hum Genet 1986;73:157–63.
36 Boyles JK, Zoellner CD, Anderson LJ, et al.A role for apoli-
poprotein E, apolipoprotein A-I, and low density lipopro-
tein receptors in cholesterol transport during regeneration
and remyelination of the rat sciatic nerve. J Clin Invest
1989;83:1015–31.
37 Schneeberger SA, Iwahashi CK, Hjelmeland LM, et al.
Apolipoprotein E in the subretinal fluid of rhegmatogenous
and exudative retinal detachments. Retina 1997;17:38–43.
38 Strittmacher WJ, Saunders AM, Schmedel DE, et al.Apoli-
poprotein E: high avidity binding to b-amyloid and
increased frequency of type 4 allele in late-onset familial
Alzheimers disease. Proc Natl Acad Sci USA 1993;90:1977–
81.
39 Strittmacher WJ, Roses AD. Apolipoprotein E and Alzhe-
imer disease. Proc Natl Acad Sci USA 1995;92:4725–7.
40 Van der Schaft TL, Mooy CM, de Bruijn WC, et al.
Immunohistochemical light and electron microscopy of
basal laminar deposit. Graefes Arch Clin Exp Ophthalmol
1994;232:40–6.
Video Report (www.bjophthalmol.com)
Capsule staining and mature cataracts: a comparison of indocyanine green and trypan blue
dyes. D F Chang
The APO*E3-Leiden mouse as an animal model for basal laminar deposit 1419
www.bjophthalmol.com
 on 28 November 2006 bjo.bmj.comDownloaded from 
